New Directions In STD Treatment - University of Hawaii

More documents

Recommendations

Info

Key Questions General Approach CDC STD Treatment Guidelines Enlistment of Subject Matter Expert Systematic Review of Evidence Background papers; Tables of evidence Guidelines Meeting 2005 Experts in field as consultants Answer the “Key Questions” Rate the quality of the evidence Identify critical gaps in knowledge (research agenda) Write the Guidelines document
Challenging Management Dilemmas in the 2006 STD Treatment Guidelines � Targeted screening, expedited partner treatment, re-testing after treatment for CT and GC � LGV emergence in MSM � Syphilis diagnosis with EIA and management in HIV-infected individuals � Antimicrobial resistance � GC, Syphilis and Trich � Age- and risk-based empiric treatment for cervicitis � Role of HSV serologic testing and suppressive therapy to prevent transmission
Page 1 and 2: New Directions in STD Treatment: Hi
Page 3: CDC 2006 STD Treatment Guidelines D
Page 7 and 8: Sexual History Taking: The 5 P’s
Page 9 and 10: Recommend Nucleic Acid Amplificatio
Page 11 and 12: Percent Screened Estimated Chlamydi
Page 13 and 14: STD Screening for MSM STD Site Type
Page 15 and 16: Prevalence of rectal chlamydia and
Page 17 and 18: Prevalence of pharyngeal chlamydia
Page 19 and 20: C. trachomatis NAAT Testing …not
Page 21 and 22: Chlamydia Treatment in Pregnancy Re
Page 23 and 24: Percent 16 14 12 10 Infection Durin
Page 25 and 26: Provider Barriers to PDPT, CA 2002
Page 27 and 28: Gonorrhea Screening in Females �
Page 29 and 30: Percent of Neisseria gonorrhoeae Is
Page 31 and 32: Gonorrhea Treatment of Urogenital I
Page 33 and 34: Lymphogranuloma Venereum (LGV) C. t
Page 35 and 36: LGV Proctocolitis: Serologic Diagno
Page 37 and 38: Phil and the Penis on the Go
Page 39 and 40: The Three “R”s of Syphilis �
Page 41 and 42: Latent Syphilis � No clinical man
Page 43 and 44: Syphilis EIA Tests �Treponemal te
Page 45 and 46: Criteria for CSF Examination � Ne
Page 47 and 48: Syphilis Resistant to Azithromycin!
Page 51 and 52: HSV Issues � Role of type-specifi
Page 53 and 54: Rates of Transmission of HSV-2 to S
Page 55 and 56:
Genital Herpes - Treatment Issues
Page 57 and 58:
HPV Issues � Clarify uses of HPV
Page 59 and 60:
Issues Regarding Anal Cancer Screen
Page 61 and 62:
Cervicitis - Diagnostic Issues �
Page 63 and 64:
Pelvic Inflammatory Disease Issues
Page 65 and 66:
PID: Oral Treatment Regimens Oral r
Page 67 and 68:
Vaginitis Trichomonas Bacterial Vag
Page 69 and 70:
Tinidazole: A New Treatment Option
Page 71 and 72:
Proposed Management Trichomoniasis
Page 73 and 74:
BV Treatment Recommended regimens:
Page 75:
STD Resources California STD/HIV Pr
show all

New Directions In STD Treatment - University of Hawaii

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?